Lionco Pharmaceutical Group Co (SHSE:603669) FFO


SHSE:603669 Lionco Pharmaceutical Group Co Ltd SHSE:603669
46 GF Score
Price ¥6.06
GF Value ¥6.81
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Lionco Pharmaceutical Group Co FFO?

FFO (Funds from operations) only applies to REITs.

SHSE:603669
46GF Score
Lionco Pharmaceutical Group Co Ltd SHSE:603669
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lionco Pharmaceutical Group Co (SHSE:603669) Overvalued in 2026?

Based on GuruFocus' analysis, Lionco Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥6.06 is trading 11% below its estimated GF Value™ of ¥6.81. GuruFocus considers Lionco Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:603669:

  • FFO:
  • GF Value™: ¥6.81 vs. price of ¥6.06 (11% below fair value)
  • GF Score™: 46/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603669 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lionco Pharmaceutical Group Co Business Description

Address No. 20, National Highway 349, Naidong District, Shannan, CHN
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.
46GF Score

Get the complete analysis for SHSE:603669

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.06
Price
¥6.81
GF Value